Skip to main content
HR 6227 118th Congress House

Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023

Official title: To amend the Federal Food, Drug, and Cosmetic Act to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.

Introduced: November 29, 2023 Introduced by: Schweikert, David Republican · Arizona See on congress.gov
Health Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationHealth promotion and preventive carePrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 10, 2023
Referred to the Subcommittee on Health.
Nov 3, 2023
Referred to the House Committee on Energy and Commerce.
Nov 3, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action November 10, 2023

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023

This bill expands the priority-review voucher program for tropical diseases to include coccidioidomycosis (also known as Valley fever). A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.

 Related & companion bills 3
  • S 3220 Related bill A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of …
  • HR 6731 Related bill FORWARD Act of 2023
  • S 3464 Related bill FORWARD Act of 2023
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 35
All 35 Democratic 11 Republican 15
R
Fong, Vince
California · Jul 22, 2024
 R
Crenshaw, Dan
Texas · Mar 13, 2024
 R
Harshbarger, Diana
Tennessee · Mar 13, 2024
 R
Balderson, Troy
Ohio · Feb 23, 2024
Bucshon, Larry
· Feb 23, 2024
 D
Salinas, Andrea
Oregon · Feb 23, 2024
 R
Pfluger, August
Texas · Feb 5, 2024
 R
Bice, Stephanie I.
Oklahoma · Jan 11, 2024
 D
Leger Fernandez, Teresa
New Mexico · Jan 11, 2024
 D
Fletcher, Lizzie
Texas · Dec 19, 2023
 D
Lee, Susie
Nevada · Dec 19, 2023
 R
Miller-Meeks, Mariannette
Iowa · Dec 19, 2023
 R
Moore, Blake D.
Utah · Dec 19, 2023
 R
Joyce, John
Pennsylvania · Dec 13, 2023
 D
Mullin, Kevin
California · Dec 13, 2023
 D
Peters, Scott H.
California · Dec 5, 2023
 R
Obernolte, Jay
California · Dec 4, 2023
 R
LaMalfa, Doug
California · Nov 29, 2023
 D
Pettersen, Brittany
Colorado · Nov 29, 2023
 D
Stansbury, Melanie A.
New Mexico · Nov 29, 2023
 D
Swalwell, Eric
California · Nov 29, 2023
Lesko, Debbie
· Nov 8, 2023
Armstrong, Kelly
· Nov 3, 2023
Burgess, Michael
· Nov 3, 2023
Caraveo, Yadira
· Nov 3, 2023
 R
Ciscomani, Juan
Arizona · Nov 3, 2023
 D
Costa, Jim
California · Nov 3, 2023
 R
De La Cruz, Monica
Texas · Nov 3, 2023
 D
Gallego, Ruben
Arizona · Nov 3, 2023
 D
Grijalva, Raúl M.
Arizona · Nov 3, 2023
 D
Levin, Mike
California · Nov 3, 2023
McCarthy, Kevin
· Nov 3, 2023
 R
Self, Keith
Texas · Nov 3, 2023
Steel, Michelle
· Nov 3, 2023
 R
Valadao, David G.
California · Nov 3, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6227: Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-6227/
MLA
"H.R. 6227: Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-6227/.
Bluebook (legal)
H.R. 6227, 118th Cong. (2026), https://openamerica.io/bill/118-HR-6227/.
Markdown link
[H.R. 6227: Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023](https://openamerica.io/bill/118-HR-6227/)
Report a problem